MAPK8 and metabolic dysfunction-associated steatohepatitis: Furthermore, we discovered that a small‐molecule inhibitor, UNC6934, inhibited the histone modification of NSD2, thereby blocking the ERN1–JNK axis and alleviating NSD2‐induced intestinal barrier impairment and NASH progression in HFCD‐fed mice.